News

The approval of Syfovre makes it the first and only approved treatment for GA in Australia.

The approval of Syfovre makes it the first and only approved treatment for GA in Australia.

Recipients will be awarded $100,000 to support a collaborative project related to glaucoma

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the genetic defects in the BBS1 gene.

The centre will facilitate research and access to resources for the 450,000 residents of the UK who are affected by sight and hearing loss

The AI-READI project aims to establish fair, equitable, and ethical access to big data, enhancing artificial intelligence’s ability to diagnose systemic diseases and drive progress in ophthalmology research.

The company states LYNX is the world’s first and only pattern scanning laser indirect ophthalmoscope and is battery-powered to provide surgeons with an untethered laser solution.

Alice T. Epitropoulos, MD, FACS, outlines her approach to managing evaporative dry eye. This includes diagnosing meibomian gland dysfunction, using thermal pulsation to clear gland blockages, and ensuring long-term results with advanced treatments and patient education.

The investigators found that the premature births to be associated with vascular changes on ocular coherence tomography-angiography.

Diana V. Do, MD, spoke on behalf of the HELIOS investigators at the Hawaiian Eye and Retina 2025 Meeting, in Kauai, HI

The “Triangle sign” seen on ultrasound is a “distinctive and reliable” ultrasound feature for differentiating total choroidal detachments and suprachoroidal hemorrhages.

Funds from the Inasmuch Foundation and The Samuel Roberts Noble Foundation will support the purchase of equipment, including computerized eye simulators, a laser injector, and a device for measuring the electrical resistance of cells.

The meetings support the company’s submission for its bioengineered corneal implants to eliminate corneal blindness.

The investigators found that the premature births to be associated with vascular changes on ocular coherence tomography-angiography.

Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline and follow-up visits that included measurements of the BCVA and visual fields in 568 eyes of 284 patients.

The NeurEYE research team will use millions of eye scans from Scottish optometrists to create the data set.

Ultrasounds reveal the distinct feature within the vitreous anterior, a promising diagnostic indicator for ocular pathologies

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

DRSS stable/improved with OKT-TKI; drug well tolerated

ARCATUS or ARVN001 was developed by Clearside Biomedical and commercialised in the Asia-Pacific region by Arctic Vision

ARCATUS or ARVN001, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries is formally known as XIPERE in the United States and was developed by Clearside Biomedical.

The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with retinitis pigmentosa.

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

Topline data results are expected in February 2025.

Changes can result in bacterial contamination, loss of drug activity, and inflammation

Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia progressed at a rate of −0.17 D annually after switching to single-vision lenses.

The study findings suggest that patients should be educated about adherence to cold storage guidelines

Participants wore high-add multifocal soft contact lenses for 2 years and single-vision lenses during the third year to determine if rebound occurred